Under construction – not a live service
Sign in
Taking people in United StatesNo phase

Tests a behavior and thinking therapy for teens with non-epileptic seizures

Tests ReACT therapy in 11 to 18 year olds with psychogenic non-epileptic seizures.

Plain-language title generated from the registry record
Registry title: Retraining and Control Therapy (ReACT) R33 Phase

Key facts

Where
Birmingham, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 11 and 18 years old?

Source: NCT06007053, who can take part

Where in United States

  • University of Alabama at BirminghamBirmingham, United StatesTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
University of Alabama at Birmingham
Trial code
NCT06007053
Record updated
17 March 2026
Original description
The purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, episodes resembling epileptic seizures but with no correlated epileptiform activity). 11-18-year-olds diagnosed with PNES will engage in twelve sessions of either ReACT or supportive therapy. Sense of control over actions will be measured by the magic and turbulence task, a well-validated measure of sense of control. Participants will complete the cold pressor test (CPT) in which participants hold their hand in cool water for as long as possible up to 3 minutes. Catastrophic symptom expectations in response to the CPT will be measured by Pain Catastrophizing Scale for Children (PCS-C), pain tolerance (time with hand in water) and cortisol response. Target assessments occur 7 days before treatment, 7 days after 12th treatment session, and 2 months after the 12th treatment session. Long term follow-up assessments will occur 6 months and 12 months after the 12th treatment session. PNES frequency will be measured from 30 days before to 12 months after treatment.Read full original descriptionShow less

Retraining and Control Therapy (ReACT): Sense of Control and Catastrophic Symptom Expectations as Targets of a Cognitive Behavioral Treatment for Pediatric Psychogenic Non-epileptic Seizures (PNES) - R33 Phase

The purpose of this study is to assess sense of control and catastrophic symptom expectations as targets for Retraining and Control Therapy (ReACT- an intervention focused on changing behaviors and thoughts) for treatment of pediatric psychogenic non-epileptic seizures (PNES, episodes resembling epileptic seizures but with no correlated epileptiform activity). 11-18-year-olds diagnosed with PNES will engage in twelve sessions of either ReACT or supportive therapy. Sense of control over actions will be measured by the magic and turbulence task, a well-validated measure of sense of control. Participants will complete the cold pressor test (CPT) in which participants hold their hand in cool water for as long as possible up to 3 minutes. Catastrophic symptom expectations in response to the CPT will be measured by Pain Catastrophizing Scale for Children (PCS-C), pain tolerance (time with hand in water) and cortisol response. Target assessments occur 7 days before treatment, 7 days after 12th treatment session, and 2 months after the 12th treatment session. Long term follow-up assessments will occur 6 months and 12 months after the 12th treatment session. PNES frequency will be measured from 30 days before to 12 months after treatment.

Inclusion: 11-18 years old; Diagnosis of psychogenic non-epileptic seizures by a medical doctor using video-EEG; Family member (parent/guardian if a minor) willing to participate and that the subject with PNES chooses.

Exclusion: Participation in other therapy during the study; Comorbid Epilepsy; Other paroxysmal nonepileptic events (e.g. episodes related to hypoxic-ischemic phenomena, sleep disorders or migraine-associated disorders); Severe mental illness (delusions/hallucinations); Exclusion for CPT:; Blood pressure >130/80 mmHg for adolescents greater than or equal to 13 years old; Either systolic and/or diastolic blood pressure greater than or equal to 95% based on sex and age for children less than 13 years old; Less than 4 PNES per month; Severe intellectual disability.

ClinicalTrials.gov NCT06007053